Insider Buy ·Filed Oct 22, 2026
Insider cluster: 1 insiders, $89K total
Actionable Insight ▲ Bullish
Monitor for additional insider buying or a material catalyst (e.g., pipeline update) to confirm conviction.
Latest settled — T+1d ⚠ clustered
AGMB ▼ -2.27% at T+1d
LONG call ✗ call lost -2.27% · α vs SPY -1.75% · entry $9.26 → $9.05
T+1d
-2.27%
call -2.27% · α -1.75%
$9.05
settled 3d ago
T+5d
Pending
in 3d
T+20d
Pending
in 24d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Director David R. Epstein purchased 10,000 shares of AgomAb Therapeutics for $89K in two open-market trades on October 21, 2026, at an average price of ~$8.88.
Key Financial Metrics
Direction
buying
Total Value
$89.0K
Insiders
1
Key Facts
- Director David R. Epstein purchased 10,000 shares total for $89K on October 21, 2026.
- Trades were open-market purchases (code P) at $8.90 and $8.86 per share.
- This is a single insider conviction buy, not a cluster.
Financial Impact
$89K in insider purchases by a director.
insider ownership
Risk Factors
- The $89K purchase is small relative to market cap and may not signal a major inflection.
- No other insiders bought shares, limiting the signal's strength.
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001445826-26-000015 |
14 reports for AGMB
71% Hit rate @ T+5 Went positive at some point 5 of 7 best @ T+5▲ +6.98%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | Insider Buy | $9.26 | awaiting T+5 | — | $9.05 (−2.27%) |
Oct 13, 2026 12d ago | 6-K | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $9.05 (+4.14%) |
Oct 13, 2026 12d ago | Press Release | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $9.05 (+4.14%) |
Oct 1, 2026 25d ago | 6-K | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $9.05 (+4.62%) |
Oct 1, 2026 25d ago | Press Release | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $9.05 (+4.62%) |
Sep 14, 2026 5w ago | 6-K | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $9.05 (−25.58%) |
Sep 14, 2026 5w ago | Press Release | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $9.05 (−25.58%) |
Sep 11, 2026 6w ago | 6-K | $12.28 $11.70 | ▼ −4.72% | ▼ −4.83% | $9.05 (−26.30%) |
Aug 10, 2026 10w ago | 6-K | $14.85 $13.73 | ▼ −7.54% | ▼ −7.14% | $9.05 (−39.06%) |
Jun 23, 2026 17w ago | 6-K | $12.68 $11.87 | ▼ −6.39% | ▼ −8.10% | $9.05 (−28.63%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 1h 57m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers